Form 8-K - Current report:
SEC Accession No. 0001683168-19-003157
Filing Date
2019-10-03
Accepted
2019-10-03 16:01:29
Documents
3
Period of Report
2019-09-20
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pharmacyte_8k.htm 8-K 18733
2 CERTIFICATE OF AMENDMENT pharm_ex0301.htm EX-3.1 13943
3 CERTIFICATE OF DESIGNATIONS pharm_ex0302.htm EX-3.2 31113
  Complete submission text file 0001683168-19-003157.txt   65159
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

EIN.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 333-68008 | Film No.: 191135545
SIC: 2836 Biological Products, (No Diagnostic Substances)